Article

Metabolic markers distinguish COVID-19 from other intensive care patients and show potential to stratify for disease risk

2021-01-16

Abstract excerpt

Coronavirus disease 2019 (COVID-19) is a viral infection affecting multiple organ systems of great significance for metabolic processes. Thus. there is increasing interest in metabolic and lipoprotein signatures of the disease and early analyses have demonstrated metabolic pattern typical for atherosclerotic and hepatic damage in COVID-19 patients. However, it remains unclear whether these are specific for COVID-1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fcc883e1-7c43-50fb-b8f4-c072cc77274f
DOI: 10.1101/2021.01.13.21249645

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolic markers distinguish COVID-19 from other intensive care patients and show potential to stratify for disease riskDOI 10.1101/2021.01.13.21249645Read

Metabolic predictors of COVID-19 mortality and severity: A Survival AnalysisSemantic proximity Read

COVID-19: A complex disease with a unique metabolic signature.Semantic proximity Read

Metabolic and immune markers for precise monitoring of COVID-19 severity and treatmentSemantic proximity Read

Role of Multiomics Data to Understand Host–Pathogen Interactions in COVID-19 PathogenesisSemantic proximity Read

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19Semantic proximity Read

Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics AnalysisSemantic proximity Read

COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations.Semantic proximity Read

Clinical Study Protocol of the ‘Biomarkers of Severity of COVID-19 Patients’ (BIOMARCOVID) ProjectSemantic proximity Read

Identification of distinct phenotypes and improving prognosis using metabolic biomarkers in COVID-19 patients.Semantic proximity Read

Altered Lipid Profile in COVID-19 Patients and Metabolic ReprogrammingSemantic proximity Read

Diagnostic, Prognostic and Mechanistic Biomarkers of COVID-19 Identified by Mass Spectrometric MetabolomicsSemantic proximity Read

Predictive biomarkers of ICU and mechanical ventilation duration in critically-ill COVID19 patientsSemantic proximity Read